TB4 lowered oxidative stress and lipid peroxidation, boosted antioxidants, suppressed inflammation by inhibiting nuclear factor kappa B, and prevented liver fibrosis [38]
Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
Description Zzz Sleep is a triple-action research nasal spray combining three small CNS-active peptides, each targeting a distinct axis of sleep, stress regulation, and circadian neurobiology: Pinealon (a Khavinson tripeptide bioregulator with pineal-derived origins and serotonin pathway research interest), DSIP (Delta Sleep-Inducing Peptide, a nonapeptide associated with slow-wave sleep architecture), and Selank (a synthetic heptapeptide anxiolytic with documented neuropsychiatric research applications in Russia)
It also increased acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activity, key enzymes that modulate acetylcholine, the neurotransmitter crucial for learning and memory [1]
